Physician profile
Kyle R Eberlin
NPI 1386844165
$445,249.51
in general payments reported to CMS, 2019-2025
21 companies · $35K in 2025
The $35K reported for 2025 was more than what 98% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108K · 2020: $22K · 2021: $44K · 2022: $55K · 2023: $115K · 2024: $66K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $84K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $80K · Travel and Lodging: $21K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Food and Beverage: $11K · Honoraria: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $83,705.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $79,737.50 |
| Travel and Lodging | $20,514.65 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,843.75 |
| Food and Beverage | $11,183.81 |
| Honoraria | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $267,587.37 | 2019-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Integra Lifesciences Corporation | $109,540.64 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Checkpoint Surgical, INC | $29,385.24 | 2019-2025 | Checkpoint Stimulators |
| Biocircuit Technologies INC | $15,805.82 | 2024-2025 | Nerve Tape |
| Medical Device Business Services, INC. | $13,886.50 | 2019-2022 | |
| Bioventus LLC | $4,178.73 | 2021-2023 | Stimrouter Implantable Kit |
| Tulavi Therapeutics, INC. | $1,697.01 | 2025 | Allay Nerve Cap - Small Nerve Set |
| Trimed, INC. | $681.71 | 2022-2024 | |
| Synthes Gmbh | $500.00 | 2022 | |
| Bioness INC | $408.38 | 2020-2021 | |
| Tela Bio, INC. | $362.55 | 2021-2024 | Ovitex 2s |
| Sonex Health, INC. | $347.84 | 2022 | |
| Derma Sciences, INC. | $280.54 | 2019 | |
| Alafair Biosciences, INC. | $169.08 | 2025 | Versawrap |
| Allergan, INC. | $139.55 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $96.56 | 2020 | |
| Endo USA, INC. | $54.01 | 2025 | Xiaflex |
| Mentor Worldwide LLC | $49.90 | 2024 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Aroa Biosurgery Incorporated | $37.60 | 2024 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $25.26 | 2024 | |
| Kerecis Limited | $15.22 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Eberlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.